Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

GSK2292767

😃Good
Catalog No. T6850Cas No. 1254036-66-2

GSK2292767 is a potent and selective inhibitor of PI3Kδ.

GSK2292767

GSK2292767

😃Good
Catalog No. T6850Cas No. 1254036-66-2
GSK2292767 is a potent and selective inhibitor of PI3Kδ.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$15935 days35 days
5 mg$71635 days35 days
10 mg$1,28035 days35 days
25 mg$2,88035 days35 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products. However, due to objective factors, there is a small probability that the synthesis may not be successful during the R&D process. We appreciate your understanding. If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
GSK2292767 is a potent and selective inhibitor of PI3Kδ.
Targets&IC50
PI3Kδ:10.1 (pIC50)
In vitro
BI-847325 shows growth-inhibitory effects on BRAF-mutant and vemurafenib-resistant melanoma cells with IC50 ranging from 0.3 nM to 2 μM, and prevents colony formation in six BRAF-mutant melanoma cell lines. BI-847325 also induces apoptosis by reducing Mcl-1 expression. [1]
In vivo
GSK2292767 is highly selective for PI3Kδ over the closely related isoforms and is active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung inflammation[1].
Chemical Properties
Molecular Weight512.58
FormulaC24H28N6O5S
Cas No.1254036-66-2
SmilesC(C=1OC(C2=C3C(=CC(=C2)C=4C=C(NS(C)(=O)=O)C(OC)=NC4)NN=C3)=NC1)N5C[C@H](C)O[C@H](C)C5
Relative Density.1.360 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 93 mg/mL (181.44 mM), Sonication is recommended.
Ethanol: <1 mg/mL
H2O: <1 mg/mL
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9509 mL9.7546 mL19.5091 mL97.5457 mL
5 mM0.3902 mL1.9509 mL3.9018 mL19.5091 mL
10 mM0.1951 mL0.9755 mL1.9509 mL9.7546 mL
20 mM0.0975 mL0.4877 mL0.9755 mL4.8773 mL
50 mM0.0390 mL0.1951 mL0.3902 mL1.9509 mL
100 mM0.0195 mL0.0975 mL0.1951 mL0.9755 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GSK2292767 | purchase GSK2292767 | GSK2292767 cost | order GSK2292767 | GSK2292767 chemical structure | GSK2292767 in vivo | GSK2292767 in vitro | GSK2292767 formula | GSK2292767 molecular weight